CDC reports disparities in maternal health OUD medication treatment
Pregnant people with opioid use disorder are more likely to receive buprenorphine (a recommended treatment) if they are older, white and have public insurance, which may indicate differences in health care access and care, according to preliminary findings from a Centers for Disease Control and Prevention surveillance network used to improve health outcomes among pregnant people with OUD and their children. READ MORE
Related News Articles
Headline
The Health Resources and Services Administration Maternal and Child Health Bureau has announced grant opportunities available supporting maternal and child…
Headline
In this conversation, Southwest Health’s Kevin Carr, M.D., family medicine physician, and Melissa Carr, M.D., OB/GYN, reflect on the joy of practicing medicine…
Headline
A report issued by the Centers for Disease Control and Prevention June 11 found that 15.2% of pregnant women in the U.S. reported current alcohol consumption.…
Headline
The Drug Enforcement Administration today released a final rule implementing provisions from the Restoring Hope for Mental Health and Well-Being Act of 2022,…
Headline
A recording of a free webinar on maternity care coding hosted by the American Medical Association on June 2 is now available. Registration is required to view…
Headline
Rep. Randy Feenstra, R-Iowa, introduced the Rural Maternity Options for Medical Support Act on May 19. The bill would guarantee that beds used solely for labor…